Dr. Schrager is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2000 Washington St
320-Blue
Newton, MA 02462Phone+1 617-243-6597
Education & Training
- Massachusetts General Hospital/Brigham and Women's Hospital/Harvard Medical SchoolFellowship, Infectious Disease, 1994 - 1997
- Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 1991 - 1994
- Rutgers New Jersey Medical SchoolClass of 1991
Certifications & Licensure
- MA State Medical License 1993 - 2025
- RI State Medical License 1999 - 2004
- American Board of Internal Medicine Infectious Disease
Awards, Honors, & Recognition
- AOA 1990
Clinical Trials
- Novel Experimental COVID-19 Therapies Affecting Host Response Start of enrollment: 2021 Jul 15
Roles: Contact
Publications & Presentations
PubMed
- Real-World Dalbavancin Use for Serious Gram-Positive Infections: Comparing Outcomes Between People Who Use and Do Not Use Drugs.Sarah Zambrano, Molly L Paras, Joji Suzuki, Jeffrey C Pearson, Brandon Dionne
Open Forum Infectious Diseases. 2024-04-01 - Case 2-2010: a man with abdominal and flank pain.David M. Dudzinski, Harry M Schrager
The New England Journal of Medicine. 2010-05-20 - 2 citationsInfectious occupational exposures in dermatology--a review of risks and prevention measures. II. The pregnant dermatologist.Sarita Nori, Mary Ann Greene, Harry M Schrager, Vincent Falanga
Journal of the American Academy of Dermatology. 2005-12-01
Journal Articles
- Efficacy of Tocilizumab in Patients Hospitalized with Covid-19Naomi J Serling-Boyd, Ann E Woolley, Manish Sagar, Harry Schrager, Jorge Fleisher, Rachel S Wallwork, Arthur Y Kim, Pritha Sen, Eric Meyerowitz, Megan M Lockwood, Mich..., The New England Journal of Medicine
Press Mentions
- Old Drug, New Trick? The Rationale for the Treatment of COVID-19 with Activated Protein CFebruary 16th, 2021
- Councilors, Medical Experts Push for More in-Person Learning at Newton SchoolsJanuary 12th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: